| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/27/2013 | US20130165456 Combination |
| 06/27/2013 | US20130165453 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| 06/27/2013 | US20130165451 Compounds for inflammation and immune-related uses |
| 06/27/2013 | US20130165446 Benzo-or pyrido-imidazole derivative |
| 06/27/2013 | US20130165442 Modulators of ATP-Binding Cassette Transporters |
| 06/27/2013 | US20130165439 Chemical compounds |
| 06/27/2013 | US20130165437 Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders. |
| 06/27/2013 | US20130165436 Dihydro-Benzo-Oxazine and Dihydro-Pyrido-Oxazine Derivatives |
| 06/27/2013 | US20130165430 Composition and method for compounded therapy |
| 06/27/2013 | US20130165429 Composition and method for compounded therapy |
| 06/27/2013 | US20130165428 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/27/2013 | US20130165427 Compounds and compositions for treating chemical warfare agent-induced injuries |
| 06/27/2013 | US20130165424 Dispiropyrrolidine derivatives |
| 06/27/2013 | US20130165420 Silicone-based composition for skin treatment |
| 06/27/2013 | US20130165419 Combination anti-inflammatory ophthalmic compositions |
| 06/27/2013 | US20130165418 Opioid agonist/opioid antagonist/acetaminophen combinations |
| 06/27/2013 | US20130165417 Methods and compositions for treating ace2-related disorders |
| 06/27/2013 | US20130165407 Prebiotic Formulations and Methods of Use |
| 06/27/2013 | US20130165405 Cyclodextrin-based polymers for therapeutics delivery |
| 06/27/2013 | US20130165404 Hybrid cooperative complexes of hyaluronic acid |
| 06/27/2013 | US20130165401 Nucleoside phosphoramidates |
| 06/27/2013 | US20130165399 Therapeutic agent for inflammatory diseases, containing adenosine n1-oxide as an effective ingredient |
| 06/27/2013 | US20130165398 Concentration-enhancing drink |
| 06/27/2013 | US20130165397 Treatment of bacterial infectious diseases |
| 06/27/2013 | US20130165396 Apple Skin Extracts for Treating Cardiovascular Disease |
| 06/27/2013 | US20130165394 Amino acid composition for improving glucose tolerance |
| 06/27/2013 | US20130165393 Phospholipid and protein tablets |
| 06/27/2013 | US20130165377 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 06/27/2013 | US20130165375 Treatment of depressive disorders |
| 06/27/2013 | US20130165370 Counteracting Drug-Induced Obesity Using GLP-1 Agonists |
| 06/27/2013 | US20130165368 Antimicrobial compounds |
| 06/27/2013 | US20130164843 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164811 Dna damaging agents in combination with tyrosine kinase inhibitors |
| 06/27/2013 | US20130164721 Augmented cognitive training |
| 06/27/2013 | US20130164394 Composition for improving sexual wellness |
| 06/27/2013 | US20130164387 Novel mannopyranoside derivatives with anticancer activity |
| 06/27/2013 | US20130164386 Targeting the Alpha3 Subnit of Na+-K+-ATPase for the Treatment of Cough with Sulfenamides |
| 06/27/2013 | US20130164384 Methods of treating bowel diseases by administering a bowel cleanser and an antibiotic |
| 06/27/2013 | US20130164379 Nanoparticle micelle coated compositions |
| 06/27/2013 | US20130164377 Shell-and-core dosage form approaching zero-order drug release |
| 06/27/2013 | US20130164376 Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetylaminoisoindoline-1,3-dione |
| 06/27/2013 | US20130164375 Methods of treating hypertriglyceridemia |
| 06/27/2013 | US20130164369 Telodendrimer nanodiscs without apolipoprotein |
| 06/27/2013 | US20130164366 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164365 Formulations for treatment with glucosinolates |
| 06/27/2013 | US20130164363 Antimicrobial flush solutions |
| 06/27/2013 | US20130164358 Oral compositions comprising a zinc compound and an anti-microbial agent |
| 06/27/2013 | US20130164351 Methods of treating bacterial infections through pulmonary delivery of fusidic acid |
| 06/27/2013 | US20130164349 Pulmonary Delivery for Levodopa |
| 06/27/2013 | US20130164345 Co-Processing Method and Formulations for HIV Attachment Inhibitor Prodrug Compound and Excipients |
| 06/27/2013 | US20130164343 Compositions and methods for enhancing transport through mucus |
| 06/27/2013 | US20130164341 Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 06/27/2013 | US20130164338 Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| 06/27/2013 | US20130164337 Antimicrobial action pharmaceutical composition for parenteral administration and its production process |
| 06/27/2013 | US20130164336 Antimicrobial and anti-inflammatory action pharmaceutical composition for parenteral administration and its production process |
| 06/27/2013 | US20130164311 Composition, preparation, and use of dense chitosan membrane materials |
| 06/27/2013 | US20130164291 Method of treating inflammatory bowel disease |
| 06/27/2013 | US20130164287 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 06/27/2013 | US20130164284 Compositions and methods to treat bone related disorders |
| 06/27/2013 | US20130164283 Antibody induced cell membrane wounding |
| 06/27/2013 | US20130164282 Treatment of cancer |
| 06/27/2013 | US20130164280 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | US20130164265 Skin care compositions |
| 06/27/2013 | US20130164261 Substituted nucleotide analogs |
| 06/27/2013 | US20130164260 Antiviral compounds |
| 06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
| 06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
| 06/27/2013 | US20130164255 Immunotherapy for reversing immune suppression |
| 06/27/2013 | US20130164249 Compositions and methods for inhibiting viral and bacterial activity |
| 06/27/2013 | US20130164228 Compositions comprising gallates and gallamides |
| 06/27/2013 | US20130164218 Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents |
| 06/27/2013 | US20130164214 Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells |
| 06/27/2013 | DE102011121995A1 Drug, useful for the treatment of hypercholesterolemia, comprises a combination of statins and a cholic acid |
| 06/27/2013 | CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 06/27/2013 | CA2858257A1 Liquid activation system |
| 06/27/2013 | CA2858123A1 [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors |
| 06/27/2013 | CA2858099A1 E-selectin antagonist compounds, compositions, and methods of use |
| 06/27/2013 | CA2858096A1 Pyrazolo[1,5-a]pyrimidines as antiviral agents |
| 06/27/2013 | CA2858090A1 Pharmaceutical compositions and methods for treating gastrointestinal infections and disorders |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2857490A1 Guanine analogs as telomerase substrates and telomere length affectors |
| 06/27/2013 | CA2857344A1 Hepatitis b antiviral agents |
| 06/27/2013 | CA2857257A1 Benzyl sulfonamide derivatives as rorc modulators |
| 06/27/2013 | CA2856964A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/27/2013 | CA2856918A1 Use of chemically modified heparin derivates in sickle cell disease |
| 06/27/2013 | CA2856492A1 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use |
| 06/27/2013 | CA2856477A1 Low anticoagulant heparins |
| 06/27/2013 | CA2856448A1 Novel heterocyclic carboxamides as modulators of kinase activity |
| 06/27/2013 | CA2856179A1 2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 06/27/2013 | CA2856054A1 An inhaler comprising a tiotropium-containing-composition |
| 06/27/2013 | CA2856047A1 An inhalable medicament comprising tiotropium |
| 06/27/2013 | CA2855890A1 Dialysis precursor composition |
| 06/27/2013 | CA2855889A1 Dialysis precursor composition |
| 06/27/2013 | CA2855764A1 Tri-heterocyclic derivatives, preparation process and uses thereof |
| 06/27/2013 | CA2854248A1 2,4-diamine-pyrimidine derivative as serine/threonine kinase inhibitors |
| 06/27/2013 | CA2853779A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
| 06/27/2013 | CA2849121A1 High quality antimicrobial paint composition |
| 06/27/2013 | CA2846983A1 Methods and compositions for reducing body fat and adipocytes |
| 06/26/2013 | WO2013079493A1 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/26/2013 | EP2607484A1 Methods and means for efficient skipping of exon 45 in Duchenne Muscular Dystrophy pre-mRNA |